Benefits and challenges of cancer peer support groups: A systematic review of qualitative studies
European Journal of Cancer Care · 2022-11 · 31 (6)
DOI: 10.1111/ecc.13700 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Cancer Care, online erschienen am 14.09.2022. Verfasst von Martina Jablotschkin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Continuing Scientific Education, Catholic University of Applied Sciences, Freiburg, Germany. Hauptthemen laut MEDLINE: Self-Help Groups, Neoplasms. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Continuing Scientific Education, Catholic University of Applied Sciences, Freiburg, Germany.
- Comprehensive Cancer Center, Department of Self-Help Research, University of Freiburg Medical Center, Freiburg, Germany.
- AGP Social Research and Center for Civil Society Development, Freiburg, Germany.
ORCID-Profile: Martina Jablotschkin, Joachim Weis
Zitieren
APA
Jablotschkin, M., Binkowski, L., Markovits Hoopii, R., & Weis, J. (2022). Benefits and challenges of cancer peer support groups: A systematic review of qualitative studies. European Journal of Cancer Care, 31(6). https://doi.org/10.1111/ecc.13700
Vancouver
Jablotschkin M, Binkowski L, Markovits Hoopii R, Weis J. Benefits and challenges of cancer peer support groups: A systematic review of qualitative studies. European Journal of Cancer Care. 2022;31(6). doi:10.1111/ecc.13700
BibTeX
@article{Jablotschkin2022,
author = {Jablotschkin, Martina and Binkowski, Lena and Markovits Hoopii, René and Weis, Joachim},
title = {Benefits and challenges of cancer peer support groups: A systematic review of qualitative studies},
journal = {European Journal of Cancer Care},
year = {2022},
volume = {31},
number = {6},
doi = {10.1111/ecc.13700}
}
EUVIMED